Abstract

Metal ions are well known modulators of protein aggregation and are key players in Alzheimer’s Disease, being found to be associated to pathologic protein deposits in diseased brains. Therefore, understanding how metals influence amyloid aggregation is critical in establishing molecular mechanisms that underlie disease onset and progression. Here, we report data on the interaction of full-length human Tau protein with calcium and zinc ions, evidencing that Tau self-assembly is differently regulated, depending on the type of bound metal ion. We established that Tau binds 4 Zn2+ and 1 Ca2+ per monomer while using native mass spectrometry analysis, without inducing order or substantial conformational changes in the intrinsically disordered Tau, as determined by structural analysis using circular dichroism and Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) spectroscopies. However, Tau aggregation is found to proceed differently in the calcium- and -zinc bound forms. While the rate of aggregation, as determined from thioflavin-T (ThT) fluorescence kinetics, is highly increased in both cases, the reaction proceeds via different mechanisms, as evidenced by the absence of the lag phase in the reaction of zinc-bound Tau. Monitoring Tau aggregation using native mass spectrometry indeed evidenced a distinct distribution of Tau conformers along the reaction, as confirmed by dynamic light scattering analysis. We propose that such differences arise from zinc binding at distinct locations within the Tau sequence that prompt both the rapid formation of seeding oligomers through interactions at high affinity sites within the repeat domains, as well as amorphous aggregation, through low affinity interactions with residues elsewhere in the sequence, including at the fuzzy coat domain.

Highlights

  • Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world and it has specific features, such as progressiveness and unremitting advancement, which result in a progressive decline of cognitive functions [1]

  • We undertake a complementary approach in which native mass spectrometry (MS) is employed to analyze zinc and calcium binding to full length human Tau, upon the incubation of purified protein with an excess of each of the metal ions, under native conditions

  • Metal ion binding to aggregating proteins is a well-known regulatory mechanism of in vivo protein aggregation that is coupled to amyloid-forming age-related dementias

Read more

Summary

Introduction

Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world and it has specific features, such as progressiveness and unremitting advancement, which result in a progressive decline of cognitive functions [1]. The main metal ions that are involved in neuronal physiological activity are iron (Fe2+/Fe3+), copper (Cu2+), zinc (Zn2+), and calcium (Ca2+), whose homeostasis is important during aging [6,7]. Recent preclinical findings suggest a possible phosphorylation-independent pathway, in which Zn2+ might modulate Tau pathology, by direct-binding to Tau, and promoting its aggregation [14]. It was observed in in vitro studies that low concentrations of Zn2+ result in the acceleration of Tau fibril formation [15]. Our results lead to a conceptual model that accounts for the diverse reported effects of zinc binding to Tau aggregation

Results
Effects of Zinc and Calcium on Heparin-Induced Aggregation of Full Length Tau
Analysis of Oligomer Distribution along the Aggregation Reaction
Discussion
Materials and Methods
Dynamic Light Scattering
Circular Dichroism
ATR-FTIR
Native Mass Spectroscopy
Atomic Force Microscopy
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call